Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial.
Saved in:
| Title: | Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial. |
|---|---|
| Authors: | Ostrominski JW; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Mc Causland FR; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Claggett BL; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Desai AS; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Jhund PS; British Heart Foundation Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom., Lam CSP; National Heart Centre Singapore and Duke-National University of Singapore, Singapore., Senni M; University of Milano-Bicocca ASST Papa Giovanni XXIII Hospital, Bergamo, Italy., Shah SJ; Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Voors AA; University Medical Center Groningen, Groningen, the Netherlands., Zannad F; Université de Lorraine, Inserm Clinical Investigation Centre, CHU, Nancy, France., Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA., Schloemer P; Bayer, Research and Development, Pharmaceuticals, Berlin, Germany., Brinker M; Bayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany., Scheerer MF; Bayer AG, Global Medical Affairs, Berlin, Germany., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Electronic address: ssolomon@bwh.harvard.edu., Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. |
| Source: | JACC. Heart failure [JACC Heart Fail] 2026 Jan; Vol. 14 (1), pp. 102439. Date of Electronic Publication: 2025 Apr 02. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40208137 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ostrominski+JW%22">Ostrominski JW</searchLink>; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Mc+Causland+FR%22">Mc Causland FR</searchLink>; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Claggett+BL%22">Claggett BL</searchLink>; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Desai+AS%22">Desai AS</searchLink>; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Jhund+PS%22">Jhund PS</searchLink>; British Heart Foundation Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lam+CSP%22">Lam CSP</searchLink>; National Heart Centre Singapore and Duke-National University of Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Senni+M%22">Senni M</searchLink>; University of Milano-Bicocca ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Shah+SJ%22">Shah SJ</searchLink>; Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Voors+AA%22">Voors AA</searchLink>; University Medical Center Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zannad+F%22">Zannad F</searchLink>; Université de Lorraine, Inserm Clinical Investigation Centre, CHU, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Pitt+B%22">Pitt B</searchLink>; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Schloemer+P%22">Schloemer P</searchLink>; Bayer, Research and Development, Pharmaceuticals, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Brinker+M%22">Brinker M</searchLink>; Bayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Scheerer+MF%22">Scheerer MF</searchLink>; Bayer AG, Global Medical Affairs, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22McMurray+JJV%22">McMurray JJV</searchLink>; British Heart Foundation Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Solomon+SD%22">Solomon SD</searchLink>; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Electronic address: ssolomon@bwh.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Vaduganathan+M%22">Vaduganathan M</searchLink>; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101598241%22">JACC. Heart failure</searchLink> [JACC Heart Fail] 2026 Jan; Vol. 14 (1), pp. 102439. <i>Date of Electronic Publication: </i>2025 Apr 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101598241 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2213-1787 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222131779%22">22131779 </searchLink><i>NLM ISO Abbreviation: </i>JACC Heart Fail <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40208137 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jchf.2025.03.006 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102439 Titles: – TitleFull: Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ostrominski JW – PersonEntity: Name: NameFull: Mc Causland FR – PersonEntity: Name: NameFull: Claggett BL – PersonEntity: Name: NameFull: Desai AS – PersonEntity: Name: NameFull: Jhund PS – PersonEntity: Name: NameFull: Lam CSP – PersonEntity: Name: NameFull: Senni M – PersonEntity: Name: NameFull: Shah SJ – PersonEntity: Name: NameFull: Voors AA – PersonEntity: Name: NameFull: Zannad F – PersonEntity: Name: NameFull: Pitt B – PersonEntity: Name: NameFull: Schloemer P – PersonEntity: Name: NameFull: Brinker M – PersonEntity: Name: NameFull: Scheerer MF – PersonEntity: Name: NameFull: McMurray JJV – PersonEntity: Name: NameFull: Solomon SD – PersonEntity: Name: NameFull: Vaduganathan M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2213-1787 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: JACC. Heart failure Type: main |
| ResultId | 1 |